Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma

Cancer Gene Therapy volume 11, pages 61–72 (2004)Cite this article

Abstract

To circumvent the toxicity caused by systemic injection of cytokines, cytokine cDNA genes encoding the human interleukin IL-2 cDNA (Ad-IL-2) and murine interferon IFN-γ gene (Ad- IFN-γ) were inserted into adenoviral vectors. These constructs were used for intratumoral gene therapy of murine renal adenocarcinoma Renca tumors. Treatment with three doses of Ad-IL-2 or Ad- IFN-γ, given a day apart, was more effective than single-dose gene therapy. We found that tumor irradiation enhanced the therapeutic efficacy of Ad-IL-2 and Ad-IFN-γ intratumoral gene therapy. Tumor irradiation, administered 1 day prior to three doses of Ad-IL-2 treatment, was more effective than radiation or Ad-IL-2 alone, resulting in tumor growth arrest in all mice, increased survival and a consistent increase in complete tumor regression response rate. Complete responders rejected Renca tumor challenge and demonstrated specific cytotoxic T-cell activity, indicative of specific tumor immunity. The effect of radiation combined with three doses of Ad-IFN-γ was less pronounced and did not lead to tumor immunity. Histological observations showed that irradiation of the tumor prior to gene therapy increased tumor destruction and inflammatory infiltrates in the tumor nodules. These findings demonstrate that tumor irradiation improves the efficacy of Ad-IL-2 gene therapy for induction of antitumor immune response.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7–33.

    Article  CAS  PubMed  Google Scholar 

  2. Mulders P, Figlin R, deKernion JB, et al. Renal cell carcinoma: recent progress and future directions. Cancer Res. 1997;57:5189–5195.

    CAS  PubMed  Google Scholar 

  3. Chow WH, Gridley G, McLaughlin JK, et al. Protein intake and risk of renal cell cancer. J Natl Cancer Inst. 1994;86:1131–1139.

    Article  CAS  PubMed  Google Scholar 

  4. Haas GP, Hillman GG . Update on the role of immunotherapy in the management of kidney cancer. Cancer Control. 1996;3:66–71.

    Article  Google Scholar 

  5. Motzer RJ, Bander NH, Nanus DM . Renal-cell carcinoma. New England J Med. 1996;335:865–875.

    Article  CAS  Google Scholar 

  6. Kim S, Haas GP, Hillman GG . Development of immunotherapy for the treatment of malignacies refractory to conventional therapies. Cytokines Mol Ther. 1996;2:13–19.

    CAS  PubMed  Google Scholar 

  7. Hillman GG, Haas GP, Wahl WH, et al. Adoptive immunotherapy of cancer: biological response modifiers and cytotoxic cell therapy. Biotherapy. 1992;5:119–129.

    Article  CAS  PubMed  Google Scholar 

  8. Rosenberg SA, Lotze MT, Yang JC, et al. Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst. 1993;85:622–632.

    Article  CAS  PubMed  Google Scholar 

  9. Dybal EJ, Maughan RL, Sud S, et al. Synergy of radiation therapy and immunotherapy in murine renal cell carcinoma. J Urol. 1992;148:1331–1337.

    Article  CAS  PubMed  Google Scholar 

  10. Younes E, Haas GP, Dezso B, et al. Local tumor irradiation augments the response to IL-2 therapy in a murine renal adenocarcinoma. Cell Immunol. 1995;165:243–251.

    Article  CAS  PubMed  Google Scholar 

  11. Dezso B, Haas GP, Hamzavi F, et al. The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases. Clin Cancer Res. 1996;2:1543–1552.

    CAS  PubMed  Google Scholar 

  12. Hillman GG, Visscher D, Ali E, et al. Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model. Cell Immunol. 1995;160:257–263.

    Article  CAS  PubMed  Google Scholar 

  13. Hillman GG, Visscher D, Hamzavi F, et al. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with IL-4. Clin Cancer Res. 1997;3:1799–1806.

    CAS  PubMed  Google Scholar 

  14. Addison CL, Braciak T, Ralston R, et al. Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. Proc Natl Acad Sci USA. 1995;92:8522–8526.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Addison CL, Bramson JL, Hitt MM, et al. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors. Gene Ther. 1998;5:1400–1409.

    Article  CAS  PubMed  Google Scholar 

  16. Cordier L, Duffour MT, Sabourin JC, et al. Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Ther. 1995;2:16–21.

    CAS  PubMed  Google Scholar 

  17. Huang H, Chen SH, Kosai K, et al. Gene therapy for hepatocellular carcinoma: long-term remission of primary and metastatic tumors in mice by interleukin-2 gene therapy in vitro. Gene Ther. 1996;3:980–987.

    CAS  PubMed  Google Scholar 

  18. Toloza EM, Hunt K, Swisher S, et al. In vitro cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther. 1996;3:11–17.

    CAS  PubMed  Google Scholar 

  19. Saffran DC, Horton HM, Yankauckas MA, et al. Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+T-cell immunity. Cancer Gene Ther. 1998;5:321–330.

    CAS  PubMed  Google Scholar 

  20. Slos P, De Meyer M, Leroy P, et al. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity. Cancer Gene Ther. 2001;8:321–332.

    Article  CAS  PubMed  Google Scholar 

  21. Chartier C, Degryse E, Gantzer M, et al. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol. 1996;70:4805–4810.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Chroboczek J, Bieber F, Jacrot B . The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology. 1992;186:280–285.

    Article  CAS  PubMed  Google Scholar 

  23. Fallaux FJ, Bout A, van der Velde I, et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther. 1998;9:1909–1917.

    Article  CAS  PubMed  Google Scholar 

  24. Lusky M, Christ M, Rittner K, et al. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2a, or E1/E4 deleted. J Virol. 1998;72:2022–2032.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Hillman GG, Maughan RL, Grignon DJ, et al. Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model. Clin Cancer Res. 2001;7:136–144.

    CAS  PubMed  Google Scholar 

  26. Zeng M, Cerniglia GJ, Eck SL, et al. High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation. Hum Gene Ther. 1997;8:1025–1032.

    Article  CAS  PubMed  Google Scholar 

  27. Hillman GG, Maughan RL, Grignon DJ, et al. Responsiveness of experimental prostate carcinoma bone tumors to neutron or photon radiation combined with cytokine therapy. Int J Rad Onc Biol Phys. 2003;56:1426–1437.

    Article  CAS  Google Scholar 

  28. Bellone M, Iezzi G, Rovere P, et al. Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol. 1997;159:5391–5399.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Barbara Ann Karmanos Cancer Institute at Wayne State University School of Medicine and Harper Hospital, Detroit, 48201, Michigan, USA

    Gilda G Hillman, Yu Wang, Jennifer L Wright, Andrey Layer, Mark Yudelev & Jeffrey D Forman

  2. Transgene SA, 11 Rue de Molsheim, Strasbourg, 67085, France

    Philippe Slos & Micael De Meyer

  3. Department of Pathology, Barbara Ann Karmanos Cancer Institute at Wayne State University School of Medicine and Harper Hospital, Detroit, 48201, Michigan, USA

    Mingxin Che

Authors
  1. Gilda G Hillman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philippe Slos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jennifer L Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrey Layer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Micael De Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mark Yudelev
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mingxin Che
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jeffrey D Forman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gilda G Hillman.

Additional information

This work was supported by Transgene SA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hillman, G., Slos, P., Wang, Y. et al. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma. Cancer Gene Ther 11, 61–72 (2004). https://doi.org/10.1038/sj.cgt.7700656

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700656

Keywords

This article is cited by

Search

Advanced search

Quick links